Intermonte on Monday upgraded biotechnology company DiaSorin (DIA.MI) to outperform from neutral and raised its price target to 90.00 euros from 74.00 euros.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)